HOPA is committed providing high quality education that is strongly integrated with HOPA’s core passion to support pharmacy practitioners and promote and advance Hematology/Oncology Pharmacy to optimize the care of individuals affected by cancer. HOPA strives to become the destination of choice for quality education focused on creating competent hematology/oncology pharmacists with sound domain knowledge, skills and managerial acumen.  Below is the full spectrum of education offerings – you may also sort by content area, date, delivery method, and if it offers BCOP recertification credit.

Update on Investigational Drugs 

Originally presented at HOPA's 13th Annual Conference, March 2017.

This session will discuss a variety of agents, including mechanism of action, and recent published information when applicable. The focus will be on medications that are in early phase trials. The information in this session is applicable for most attendees.

Learning Objectives

  • Discuss current and emerging pathways targeted at the development of anticancer drugs.
  • Describe the rationale and recent clinical findings for newly developed therapies.


Casey Williams, PharmD BCOP FHOPA

Casey Williams received a bachelor of science degree in biology and chemistry from Buena Vista University in 1996 and the PharmD degree from Creighton University in 2000; he subsequently completed his PGY-1 residency in pharmacy practice at the University of North Carolina and his PGY-2 oncology practice residency at the University of Texas/Audie L. Murphy Memorial VA Hospital. He has clinical faculty appointments at the University of Kansas School of Pharmacy, South Dakota State University School of Pharmacy, and the University of South Dakota School of Medicine. His current research focus is in the use of cancer genomics and translational therapeutics to better understand the role that specific genes have on the activity of various cancer treatments.

This activity has been approved for .125 CEUs

Activity type

Research; Patient Management & Therapeutics

Accreditation Statement

logo acpe

The Hematology/Oncology Pharmacy Association (HOPA) is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. An ACPE statement of credit will be issued only upon completion of the pre/post- assessment and a post-activity evaluation form. ACPE credit must be claimed by March 29, 2020.

This activity has been approved for .1 CEU

This course is also included as part of the Best of AC2017 Bundle product.

Release Date: August 31, 2017

Expiration Date: March 29, 2020

Member: $25

Non-Member: $35

Purchase Now